Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Antibodies Studied
Download: Excel (XLSX), Comma-separated (CSV)
- 1 Antibody
HMS LINCS ID | Name | Alternative Names | Clone Name | LINCS ID | Resource Identification Initiative ID | Nominal Protein Target HMS LINCS ID(s) |
---|---|---|---|---|---|---|
80078-1 | Cetuximab | Erbitux |
- 1 Antibody